Production (Stage)
Generation Bio Co.
GBIO
$0.3691
-$0.0139-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.77% | -39.63% | 25.05% | 72.59% | -111.85% |
| Total Depreciation and Amortization | -3.40% | -0.34% | -6.57% | -3.73% | -0.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.26% | 111.71% | -22.03% | -94.52% | 1,598.90% |
| Change in Net Operating Assets | -1,825.94% | 88.95% | -41.99% | 67.33% | -414.00% |
| Cash from Operations | -79.68% | 19.25% | 9.23% | 32.06% | -26.90% |
| Capital Expenditure | 34.92% | -315.38% | -550.00% | 99.27% | 58.12% |
| Sale of Property, Plant, and Equipment | -36.17% | 4.44% | -56.73% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.51% | 453.67% | 6.28% | 779.12% | -48.80% |
| Cash from Investing | -95.79% | 453.07% | 5.11% | 2,286.26% | 71.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,115.38% | -95.09% | -- | -- |
| Repurchase of Common Stock | 50.00% | 12.50% | 48.39% | 75.20% | -6.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.86% | 4,900.00% | -101.28% | 287.20% | -262.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -146.50% | 898.66% | 25.72% | 71.55% | -20.73% |